Freedman MS, Clift F, Devonshire V, Emond F, et al. First-line use of higher-efficacy disease-modifying therapies in multiple sclerosis: Canadian consensus recommendations. Can J Neurol Sci 2025 Jun 9:1-28. doi: 10.1017/cjn.2025.10342.
PMID: 40485478